Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression
Clinical Psychopharmacology and Neuroscience April 1, 2015 DOI: 10.9758/cpn.2015.13.1.118 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Depression |
Abstract
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression
Citations in the library
Cited by 2
Cites 6
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- NMDA Antagonist Neurotoxicity: Mechanism and Prevention Science December 6, 1991
- Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Biological Psychiatry July 1, 2015
- Therapeutic Modalities for Treatment Resistant Depression: Focus on Vagal Nerve Stimulation and Ketamine Clinical Psychopharmacology and Neuroscience August 1, 2014
- Modulation of functional EEG networks by the NMDA antagonist nitrous oxide. PLoS One 2013
and 1 more in the library